Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;52(3):325-30.
doi: 10.1007/s13353-011-0040-6. Epub 2011 Apr 19.

Prevalence of the most frequent BRCA1 mutations in Polish population

Affiliations

Prevalence of the most frequent BRCA1 mutations in Polish population

Izabela Brozek et al. J Appl Genet. 2011 Aug.

Abstract

The purpose of our study was to establish the frequency and distribution of the four most common BRCA1 mutations in Polish general population and in a series of breast cancer patients. Analysis of the population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3819del5 (c.3700_3704del5) mutations of the BRCA1 gene were performed on a group of respectively 16,849, 13,462, 12,485 and 3923 anonymous samples collected at birth in seven Polish provinces. The patient group consisted of 1845 consecutive female breast cancer cases. The most frequent BRCA1 mutation in the general population was 5382insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respectively 11 of 13,462 (0.08%) and four of 3923 (0.1%) samples. The population prevalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer cases were, respectively, 1.9% (35/1845) and 1.2% (18/1486). Comparing these data with the population frequency, we calculated the relative risk of breast cancer for 5382insC mutation at OR = 17 and for 300T >G mutation at OR = 26. Our results, based on large population studies, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general population. Carriage of one of these mutations is connected with a very high relative risk of breast cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The contributions the mutation detection methods made to analysis pathogenic allels and representative examples of detected mutations. a - representative gels showing PCR products, b - representative DHPLC chromatograms, c - representative sequencing results confirming the presence of the mutations, RFLP - restriction fragment length polymorphism, SSCP - single-strand conformation polymorphism, ASA-PCR - allele-specific PCR, DHPLC - denaturing high performance liquid chromatography
Fig. 2
Fig. 2
Map of Poland with division into voivodeships showing geographical distribution and frequencies of BRCA1 5382insC, 300T >G, 185delAG, and 3819del5 mutations. * - only 5382insC mutation

References

    1. Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer. 2002;86:76–83. doi: 10.1038/sj.bjc.6600008. - DOI - PMC - PubMed
    1. Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet. 2005;42:602–603. doi: 10.1136/jmg.2004.024133. - DOI - PMC - PubMed
    1. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst. 2002;94:1365–1372. - PubMed
    1. Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M, et al. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecol Oncol. 2008;108:433–437. doi: 10.1016/j.ygyno.2007.09.035. - DOI - PubMed
    1. Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M, et al. Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers. J Appl Genet. 2009;50:379–384. doi: 10.1007/BF03195697. - DOI - PubMed